-
News
Longeveron Announces Achievement of Surpassing 50% Enrollment Threshold in Phase 2 ELPIS II Study of Lomecel-BTM in Hypoplastic Left Heart Syndrome
Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, announced today…
Read More » -
News
Epazz Holdings’ ZenaDrone Secured Funding to Deploy 10 ZenaDrone 1000s for Service in the Oil and Gas Sector in Houston, Texas
[ad_1] CHICAGO, IL – (NewMediaWire) – August 10, 2023 – Epazz Inc. (OTC Pink: EPAZ), a mission-critical provider of drone technology,…
Read More » -
ABVC BioPharma Regains Compliance With Nasdaq’s Minimum Bid Price Requirement
[ad_1] FREMONT, CA – (NewMediaWire) – August 10, 2023 – Fremont, CA – (NewMediaWire) – August 10, 2023 – ABVC BioPharma,…
Read More »